letterJournal of Allergy and Clinical ImmunologyApr 22, 2020HYBRID OA

Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2

DJDaniel J. JacksonWWWilliam W. BusseLBLeonard B. BacharierMKMeyer KattanGOGeorge O'connor

University of Wisconsin–Madison · Washington University in St. Louis · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

The novel coronavirus SARS-CoV-2 (COVID-19) was recognized in December 2019 as a cause of severe pneumonia and has now led to a global pandemic.1Zhou P. Yang X.L. Wang X.G. Hu B. Zhang L. Zhang W. et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin.Nature. 2020; 579: 270-273Crossref PubMed Scopus (14613) Google Scholar Respiratory illnesses caused by COVID-19 cover a range of severity. The identification of risk and protective factors for disease severity from COVID-19 is critical to direct development of new treatments and infection prevention strategies. Early large case series have identified a number of risk factors for severe disease, including older age, hypertension,…

Citation impact

590
total citations
FWCI
13.23
Percentile
100%
References
14
Citations per year

Authors

16

Topics & keywords

Topics
Keywords
  • Asthma
  • Medicine
  • Allergy
  • Coronavirus disease 2019 (COVID-19)
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Respiratory system
  • Association (psychology)
  • Immunology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding